Cornercap Investment Counsel’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-64,058
Closed -$851K 628
2022
Q3
$851K Buy
+64,058
New +$1.11M 0.16% 266
2022
Q2
Sell
-48,732
Closed -$972K 644
2022
Q1
$972K Buy
+48,732
New +$984K 0.11% 330
2020
Q4
Sell
-44,930
Closed -$782K 575
2020
Q3
$782K Buy
+44,930
New +$959K 0.11% 310
2018
Q2
Sell
-22,280
Closed -$885K 434
2018
Q1
$885K Buy
22,280
+600
+3% +$22.2K 0.13% 180
2017
Q4
$726K Buy
+21,680
New +$770K 0.1% 314
2017
Q3
Sell
-19,825
Closed -$735K 421
2017
Q2
$735K Hold
19,825
0.12% 158
2017
Q1
$557K Buy
+19,825
New +$559K 0.09% 273

Other funds holding PAHC

Cornercap Investment Counsel's PAHC Position: Q4 2022 in Review

Cornercap Investment Counsel sold out of Phibro Animal Health (PAHC) in Q4 2022, closing a stake of 64,058 shares — an estimated $851K sold.

Cornercap Investment Counsel first reported a position in PAHC in Q1 2017 and held it in 7 quarters. The position peaked at $972K in Q1 2022. 132 funds tracked by Wall St. Rank hold PAHC as of Q4 2022.

  • Cornercap Investment Counsel reported no remaining Phibro Animal Health position as of Q4 2022 after selling out during the quarter.
  • Cornercap Investment Counsel sold 64,058 Phibro Animal Health shares in Q4 2022, an estimated $851K.
  • Cornercap Investment Counsel first reported a position in Phibro Animal Health in Q1 2017 and held it in 7 quarters.
  • Cornercap Investment Counsel's Phibro Animal Health position peaked at $972K in Q1 2022.
  • 132 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2022.

Based on Cornercap Investment Counsel's 13F filing for Q4 2022, filed 13 Feb 2023.